Related Experiment Video
Updated: Apr 29, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Less understood issues: p21(Cip1) in mitosis and its therapeutic potential
N-N Kreis1, F Louwen1, J Yuan1
1Department of Gynecology and Obstetrics, J.W. Goethe-University, Frankfurt, Germany.
The cell cycle regulator p21 (also known as Cip1) is crucial for mitosis. Loss of p21 causes mitotic defects and genomic instability, while its stabilization in tumor cells suggests a role in cancer therapy.
Area of Science:
- Cell Biology
- Molecular Oncology
Background:
- p21 (Cip1) is a key regulator of cellular processes, with dual roles as a tumor suppressor and oncogene.
- Its role in mitosis, though proposed, has not been systematically investigated.
- p21 expression is modulated by p53-dependent and -independent pathways in response to cellular stress.
Purpose of the Study:
- To systematically investigate the function of p21 in mitosis.
- To elucidate the role of p21 in mitotic progression and genomic stability.
- To explore the therapeutic potential of p21 in cancer treatment.
Main Methods:
- Biochemical assays to determine p21 binding and inhibition of Cdk1/cyclin B1 activity.
- Analysis of mitotic progression, chromosome segregation, and cytokinesis in cells with and without p21.
- Investigation of p21 stabilization and localization in mitotic tumor cells treated with mitotic agents.
Main Results:
- p21 binds to and inhibits Cdk1/cyclin B1, ensuring precise mitotic progression.
- Loss of p21 leads to prolonged mitosis, chromosome segregation errors, and cytokinesis failure, promoting genomic instability.
- p21 is stabilized in the cytoplasm of mitotic tumor cells treated with paclitaxel or mitotic kinase inhibitors, correlating with cell survival.
Conclusions:
- p21 plays a critical role in regulating mitosis and maintaining genomic stability.
- Stabilized p21 in tumor cells suggests its involvement in resistance to mitotic agents and potential as a therapeutic target.
More Related Videos
15:53Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Negative Regulator Molecules
Mitogens and the Cell Cycle